110 related articles for article (PubMed ID: 17308119)
1. Antibody-mediated p53 protein therapy prevents liver metastasis in vivo.
Hansen JE; Fischer LK; Chan G; Chang SS; Baldwin SW; Aragon RJ; Carter JJ; Lilly M; Nishimura RN; Weisbart RH; Reeves ME
Cancer Res; 2007 Feb; 67(4):1769-74. PubMed ID: 17308119
[TBL] [Abstract][Full Text] [Related]
2. Antibody-mediated FOXP3 protein therapy induces apoptosis in cancer cells in vitro and inhibits metastasis in vivo.
Heinze E; Baldwin S; Chan G; Hansen J; Song J; Clements D; Aragon R; Nishimura R; Reeves M; Weisbart R
Int J Oncol; 2009 Jul; 35(1):167-73. PubMed ID: 19513564
[TBL] [Abstract][Full Text] [Related]
3. Antibody-mediated transduction of p53 selectively kills cancer cells.
Weisbart RH; Hansen JE; Chan G; Wakelin R; Chang SS; Heinze E; Miller CW; Koeffler PH; Yang F; Cole GM; Min YS; Nishimura RN
Int J Oncol; 2004 Dec; 25(6):1867-73. PubMed ID: 15547728
[TBL] [Abstract][Full Text] [Related]
4. Construction and expression of a bispecific single-chain antibody that penetrates mutant p53 colon cancer cells and binds p53.
Weisbart RH; Wakelin R; Chan G; Miller CW; Koeffler PH
Int J Oncol; 2004 Oct; 25(4):1113-8. PubMed ID: 15375563
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of mouse liver metastasis by intraportal injection of Adv-p53].
Su W; Zhang JH; Liu HW; Xiao G; Zhou XP; Sun JH; Liao CJ; Huang MX
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):818-21. PubMed ID: 18396637
[TBL] [Abstract][Full Text] [Related]
6. Design, construction, and in vitro analysis of A33scFv::CDy, a recombinant fusion protein for antibody-directed enzyme prodrug therapy in colon cancer.
Coelho V; Dernedde J; Petrausch U; Panjideh H; Fuchs H; Menzel C; Dübel S; Keilholz U; Thiel E; Deckert PM
Int J Oncol; 2007 Oct; 31(4):951-7. PubMed ID: 17786329
[TBL] [Abstract][Full Text] [Related]
7. Suppression of colorectal cancer liver metastasis and extension of survival by expression of apolipoprotein(a) kringles.
Yu HK; Kim JS; Lee HJ; Ahn JH; Lee SK; Hong SW; Yoon Y
Cancer Res; 2004 Oct; 64(19):7092-8. PubMed ID: 15466205
[TBL] [Abstract][Full Text] [Related]
8. Efficient growth inhibition of ErbB2-overexpressing tumor cells by anti-ErbB2 ScFv-Fc-IL-2 fusion protein in vitro and in vivo.
Shi M; Zhang L; Gu HT; Jiang FQ; Qian L; Yu M; Chen GJ; Luo Q; Shen BF; Guo N
Acta Pharmacol Sin; 2007 Oct; 28(10):1611-20. PubMed ID: 17883948
[TBL] [Abstract][Full Text] [Related]
9. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
10. Humoral immune responses induced by anti-idiotypic antibody fusion protein of 6B11scFv/hGM-CSF in BALB/c mice.
Chang XH; Ye X; Cui H; Feng J; Li Y; Zhu HL; Yang WL; Fu TY; Cheng HY; Guo HF
Chin Med J (Engl); 2006 Jan; 119(2):131-9. PubMed ID: 16454995
[TBL] [Abstract][Full Text] [Related]
11. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
12. Antibody-mediated delivery of interleukin-2 to the stroma of breast cancer strongly enhances the potency of chemotherapy.
Mårlind J; Kaspar M; Trachsel E; Sommavilla R; Hindle S; Bacci C; Giovannoni L; Neri D
Clin Cancer Res; 2008 Oct; 14(20):6515-24. PubMed ID: 18927291
[TBL] [Abstract][Full Text] [Related]
13. A genetically engineered anti-CD45 single-chain antibody-streptavidin fusion protein for pretargeted radioimmunotherapy of hematologic malignancies.
Lin Y; Pagel JM; Axworthy D; Pantelias A; Hedin N; Press OW
Cancer Res; 2006 Apr; 66(7):3884-92. PubMed ID: 16585217
[TBL] [Abstract][Full Text] [Related]
14. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
Song Y; Shen K; He CX
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect on the establishment of hepatic metastasis by transduction of the tissue plasminogen activator gene to murine colon cancer.
Hayashi S; Yokoyama I; Namii Y; Emi N; Uchida K; Takagi H
Cancer Gene Ther; 1999; 6(4):380-4. PubMed ID: 10419057
[TBL] [Abstract][Full Text] [Related]
16. The antibody-mediated targeted delivery of interleukin-15 and GM-CSF to the tumor neovasculature inhibits tumor growth and metastasis.
Kaspar M; Trachsel E; Neri D
Cancer Res; 2007 May; 67(10):4940-8. PubMed ID: 17510424
[TBL] [Abstract][Full Text] [Related]
17. Construction and characterization of novel, recombinant immunotoxins targeting the Her2/neu oncogene product: in vitro and in vivo studies.
Cao Y; Marks JD; Marks JW; Cheung LH; Kim S; Rosenblum MG
Cancer Res; 2009 Dec; 69(23):8987-95. PubMed ID: 19934334
[TBL] [Abstract][Full Text] [Related]
18. Restoration of transcriptional activity of p53 mutants in human tumour cells by intracellular expression of anti-p53 single chain Fv fragments.
Caron de Fromentel C; Gruel N; Venot C; Debussche L; Conseiller E; Dureuil C; Teillaud JL; Tocque B; Bracco L
Oncogene; 1999 Jan; 18(2):551-7. PubMed ID: 9927212
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of antitumour colon cancer cell vaccine modified by Escherichia coli cytosine deaminase gene].
Shen LZ; Wang JH; Wang HQ; Hua YB; Wu WX
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep; 9(5):425-8. PubMed ID: 17043966
[TBL] [Abstract][Full Text] [Related]
20. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
Alvarez-Rueda N; Leprieur S; Clémenceau B; Supiot S; Sébille-Rivain V; Faivre-Chauvet A; Davodeau F; Paris F; Barbet J; Aubry J; Birklé S
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
